Theracryf (TCF) Competitors

GBX 0.22 -0.02 (-6.38%)
As of 11:27 AM Eastern

TCF vs. HARL, ING, NWT, SPO, and VEL

Should you buy Theracryf stock or one of its competitors? MarketBeat compares Theracryf with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Theracryf include Harland & Wolff Group (HARL), Ingenta (ING), Newmark Security (NWT), Sportech (SPO), and Velocity Composites (VEL). These companies are all part of the "banking" industry.

How does Theracryf compare to Harland & Wolff Group?

Harland & Wolff Group (LON:HARL) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Harland & Wolff Group has a net margin of -49.57% compared to Theracryf's net margin of -792.17%. Harland & Wolff Group's return on equity of 0.00% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Harland & Wolff Group-49.57% N/A -16.78%
Theracryf -792.17%-37.30%-48.26%

Harland & Wolff Group has a beta of 3.14, indicating that its share price is 214% more volatile than the broader market. Comparatively, Theracryf has a beta of 1.401, indicating that its share price is 40% more volatile than the broader market.

In the previous week, Harland & Wolff Group's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.

Company Overall Sentiment
Harland & Wolff Group Neutral
Theracryf Neutral

60.8% of Harland & Wolff Group shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 16.3% of Harland & Wolff Group shares are owned by insiders. Comparatively, 23.1% of Theracryf shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Theracryf has lower revenue, but higher earnings than Harland & Wolff Group. Theracryf is trading at a lower price-to-earnings ratio than Harland & Wolff Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harland & Wolff Group£86.91M0.00-£43.09M-£0.24N/A
TheracryfN/AN/A-£5.45M-£0.13N/A

Summary

Harland & Wolff Group beats Theracryf on 6 of the 10 factors compared between the two stocks.

How does Theracryf compare to Ingenta?

Ingenta (LON:ING) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Ingenta has a net margin of 16.94% compared to Theracryf's net margin of -792.17%. Ingenta's return on equity of 24.87% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Ingenta16.94% 24.87% 7.54%
Theracryf -792.17%-37.30%-48.26%

In the previous week, Ingenta had 2 more articles in the media than Theracryf. MarketBeat recorded 2 mentions for Ingenta and 0 mentions for Theracryf. Theracryf's average media sentiment score of 0.00 beat Ingenta's score of -0.17 indicating that Theracryf is being referred to more favorably in the news media.

Company Overall Sentiment
Ingenta Neutral
Theracryf Neutral

Ingenta has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Ingenta, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ingenta£10.27M0.87£1.34M£11.995.14
TheracryfN/AN/A-£5.45M-£0.13N/A

Ingenta has a beta of 0.704, meaning that its share price is 30% less volatile than the broader market. Comparatively, Theracryf has a beta of 1.401, meaning that its share price is 40% more volatile than the broader market.

12.6% of Ingenta shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 76.8% of Ingenta shares are owned by insiders. Comparatively, 23.1% of Theracryf shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Ingenta beats Theracryf on 10 of the 12 factors compared between the two stocks.

How does Theracryf compare to Newmark Security?

Newmark Security (LON:NWT) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

In the previous week, Newmark Security's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.

Company Overall Sentiment
Newmark Security Neutral
Theracryf Neutral

Newmark Security has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market. Comparatively, Theracryf has a beta of 1.401, meaning that its share price is 40% more volatile than the broader market.

Newmark Security has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Newmark Security, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Newmark Security£24.37M0.45£134.00K£10.4811.14
TheracryfN/AN/A-£5.45M-£0.13N/A

Newmark Security has a net margin of 4.19% compared to Theracryf's net margin of -792.17%. Newmark Security's return on equity of 11.74% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Newmark Security4.19% 11.74% 2.75%
Theracryf -792.17%-37.30%-48.26%

53.3% of Newmark Security shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 52.3% of Newmark Security shares are owned by insiders. Comparatively, 23.1% of Theracryf shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Newmark Security beats Theracryf on 9 of the 10 factors compared between the two stocks.

How does Theracryf compare to Sportech?

Theracryf (LON:TCF) and Sportech (LON:SPO) are both small-cap banking companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Sportech has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Sportech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TheracryfN/AN/A-£5.45M-£0.13N/A
Sportech£26.98M0.00-£1.01M-£0.05N/A

Sportech has a net margin of 2.47% compared to Theracryf's net margin of -792.17%. Sportech's return on equity of -3.95% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Theracryf-792.17% -37.30% -48.26%
Sportech 2.47%-3.95%0.31%

Theracryf has a beta of 1.401, indicating that its share price is 40% more volatile than the broader market. Comparatively, Sportech has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

2.2% of Theracryf shares are owned by institutional investors. Comparatively, 61.3% of Sportech shares are owned by institutional investors. 23.1% of Theracryf shares are owned by insiders. Comparatively, 31.4% of Sportech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Theracryf's average media sentiment score of 0.00 equaled Sportech'saverage media sentiment score.

Company Overall Sentiment
Theracryf Neutral
Sportech Neutral

Summary

Sportech beats Theracryf on 8 of the 10 factors compared between the two stocks.

How does Theracryf compare to Velocity Composites?

Velocity Composites (LON:VEL) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

In the previous week, Velocity Composites had 3 more articles in the media than Theracryf. MarketBeat recorded 3 mentions for Velocity Composites and 0 mentions for Theracryf. Velocity Composites' average media sentiment score of 0.05 beat Theracryf's score of 0.00 indicating that Velocity Composites is being referred to more favorably in the media.

Company Overall Sentiment
Velocity Composites Neutral
Theracryf Neutral

Velocity Composites has a beta of 1.138, indicating that its stock price is 14% more volatile than the broader market. Comparatively, Theracryf has a beta of 1.401, indicating that its stock price is 40% more volatile than the broader market.

Velocity Composites presently has a consensus price target of GBX 40, indicating a potential upside of 231.95%. Given Velocity Composites' stronger consensus rating and higher probable upside, equities analysts plainly believe Velocity Composites is more favorable than Theracryf.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Velocity Composites
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Theracryf
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Velocity Composites has higher revenue and earnings than Theracryf. Velocity Composites is trading at a lower price-to-earnings ratio than Theracryf, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Velocity Composites£20.70M0.32-£2.41M-£2.00N/A
TheracryfN/AN/A-£5.45M-£0.13N/A

Velocity Composites has a net margin of -8.25% compared to Theracryf's net margin of -792.17%. Velocity Composites' return on equity of -32.89% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Velocity Composites-8.25% -32.89% -12.42%
Theracryf -792.17%-37.30%-48.26%

1.1% of Velocity Composites shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 15.2% of Velocity Composites shares are owned by company insiders. Comparatively, 23.1% of Theracryf shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Velocity Composites beats Theracryf on 10 of the 15 factors compared between the two stocks.

Get Theracryf News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCF vs. The Competition

MetricTheracryfBiotechnology IndustryMedical SectorLON Exchange
Market Cap£4.73M£494.55M£6.78B£2.77B
Dividend YieldN/A3.86%2.68%6.16%
P/E Ratio-1.693.1825.66366.66
Price / SalesN/A7,182.40554.8785,978.63
Price / CashN/A13.1346.3327.87
Price / Book0.2688.5210.697.76
Net Income-£5.45M-£96.07M£3.57B£5.89B
7 Day Performance-4.35%1.75%2.30%-0.71%
1 Month Performance-8.33%0.58%1.47%-1.20%
1 Year Performance-13.73%70.85%31.70%65.93%

Theracryf Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCF
Theracryf
N/AGBX 0.22
-6.4%
N/A-5.6%£4.73MN/AN/A10
HARL
Harland & Wolff Group
N/AN/AN/AN/A£14.49M£86.91MN/A81
ING
Ingenta
N/AGBX 89.10
-1.5%
N/A+0.2%£12.93M£10.27M7.4365,000
NWT
Newmark Security
N/AGBX 105
-4.5%
N/A+58.4%£9.90M£24.37M10.02102
SPO
Sportech
N/AN/AN/AN/A£8.40M£26.98MN/A217,000

Related Companies and Tools


This page (LON:TCF) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners